Nanoclay-reinforced HA/alginate scaffolds as cell carriers and SDF-1 delivery-platforms for bone tissue engineering

Int J Pharm. 2022 Jul 25:623:121895. doi: 10.1016/j.ijpharm.2022.121895. Epub 2022 Jun 9.

Abstract

Bone tissue engineering has come on the scene to overcome the difficulties of the current treatment strategies. By combining biomaterials, active agents and growth factors, cells and nanomaterials, tissue engineering makes it possible to create new structures that enhance bone regeneration. Herein, hyaluronic acid and alginate were used to create biologically active hydrogels, and montmorillonite nanoclay was used to reinforce and stabilize them. The developed scaffolds were found to be biocompatible and osteogenic with mMSCs in vitro, especially those reinforced with the nanoclay, and allowed mineralization even in the absence of differentiation media. Moreover, an in vivo investigation was performed to establish the potential of the hydrogels to mend bone and act as cell-carriers and delivery platforms for SDF-1. Scaffolds embedded with SDF-1 exhibited the highest percentages of bone regeneration as well as of angiogenesis, which confirms the suitability of the scaffolds for bone. Although there are a number of obstacles to triumph over, these bioengineered structures showed potential as future bone regeneration treatments.

Keywords: 3D Scaffold; Biomaterials; Bone; Nanoclay; SDF-1; Tissue Engineering.

MeSH terms

  • Alginates* / chemistry
  • Biocompatible Materials / chemistry
  • Bone Regeneration
  • Bone and Bones
  • Cell Differentiation
  • Hydrogels / chemistry
  • Osteogenesis
  • Tissue Engineering*
  • Tissue Scaffolds / chemistry

Substances

  • Alginates
  • Biocompatible Materials
  • Hydrogels